Browsing: BLASTmol

Research

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol

By NewsCancerApril 5, 20260

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping myelodysplastic and myeloproliferative features [1]. TET2 is…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC

Cilta-Cel Produces Early Responses in Smoldering Multiple Myeloma

Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure

Browsing: BLASTmol

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol

CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC

Cilta-Cel Produces Early Responses in Smoldering Multiple Myeloma

Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure

Ramucirumab Regimen Yields Noninferior OS Vs SOC in Stage IV NSCLC

CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC

Cilta-Cel Produces Early Responses in Smoldering Multiple Myeloma

Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure

Ramucirumab Regimen Yields Noninferior OS Vs SOC in Stage IV NSCLC

Latest Post

CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC

Cilta-Cel Produces Early Responses in Smoldering Multiple Myeloma

Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure

Subscribe to Updates

What's Hot

Browsing: BLASTmol